mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.006 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.007 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.31 |
0.007 |